Health Technology · Medical Specialties · NSE: LENSKART · data 2026-10-09

Lenskart Solutions Limited

Health check: Average (6/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹677.65

Market cap

₹1,13,751 cr

P/E

178.9

P/B

—

ROE

6.7%

ROCE

7.8%

Debt / equity

0.35

Dividend yield

0.00%

1-year return

68.6%

52-week high

₹725

52-week low

₹356.1

Operating margin

9.2%

Growth

Revenue (last 12 months)	₹9,634 cr
Net profit (last 12 months)	₹655 cr
Sales growth, 3 years (yearly)	33.5%
Profit growth, 3 years (yearly)	—

Similar companies

Molbio Diagnostics Limited (MOLBIO) · Poly Medicure Limited (POLYMED) · Standard Engineering Technology Ltd (SETL) · Virtuoso Optoelectronics Limited (VOEPL) · Q-Line Biotech Limited (QLINE)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open LENSKART in NSE Scanner →